Search Results - "Menoyo, José"
-
1
Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study
Published in American journal of nephrology (01-09-2016)“…Hyperkalemia is common in patients receiving maintenance hemodialysis. However, few studies have examined the association between serum potassium level and…”
Get more information
Journal Article -
2
Defining reliable disability outcomes in multiple sclerosis
Published in Brain (London, England : 1878) (01-11-2015)“…Prevention of irreversible disability is currently the most important goal of disease modifying therapy for multiple sclerosis. The disability outcomes used in…”
Get full text
Journal Article -
3
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55 - IL6ST Gene Region in Immature Dendritic Cells
Published in Frontiers in immunology (17-01-2022)“…Intronic single-nucleotide polymorphisms (SNPs) in the gene are associated with the risk for multiple sclerosis (MS) and rheumatoid arthritis by genome-wide…”
Get full text
Journal Article -
4
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
Published in Patient preference and adherence (30-06-2023)“…Hopelessness is a risk factor for depression and suicide. There is little information on this phenomenon among patients with relapsing-remitting multiple…”
Get full text
Journal Article -
5
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis
Published in Multiple sclerosis and related disorders (01-11-2024)“…•Illness-related uncertainty affects mental well-being and long-term planning.•Uncertainty is common in patients who overcome the disease's initial…”
Get full text
Journal Article -
6
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale
Published in Multiple sclerosis journal - experimental, translational and clinical (01-04-2024)“…A multicenter study involving 204 adults with relapsing-remitting multiple sclerosis (RRMS) assessed the dimensionality and item characteristics of the…”
Get full text
Journal Article -
7
Acute disseminated encephalomyelitis: A rare autoimmune complication of herpes simplex encephalitis in the adult
Published in Clinical neurology and neurosurgery (01-12-2018)“…•Neurological deterioration after herpes encephalitis occurs in 25% of patients.•Relapses respond to an infectious or autoimmune etiology.•Viral persistence…”
Get full text
Journal Article -
8
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
Published in Multiple sclerosis and related disorders (01-01-2018)“…Fingolimod is an efficient and safe drug for treating relapsing-remitting multiple sclerosis (RRMS). In vivo, fingolimod is phosphorylated and binds to…”
Get full text
Journal Article -
9
-
10
Defining secondary progressive multiple sclerosis
Published in Brain (London, England : 1878) (01-09-2016)“…A number of studies have been conducted with the onset of secondary progressive multiple sclerosis as an inclusion criterion or an outcome of interest…”
Get full text
Journal Article -
11
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Published in Brain (London, England : 1878) (01-09-2017)“…Timely initiation of effective therapy is crucial for preventing disability in multiple sclerosis; however, treatment response varies greatly among patients…”
Get full text
Journal Article -
12
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-12-2016)“…BackgroundAge at onset (AAO) in multiple sclerosis (MS) is an important marker of disease severity and may have prognostic significance. Understanding what…”
Get full text
Journal Article -
13
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-04-2019)“…ObjectiveOral immunotherapies have become a standard treatment in relapsing-remitting multiple sclerosis. Direct comparison of their effect on relapse and…”
Get full text
Journal Article -
14
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
Published in Annals of neurology (01-03-2015)“…Objective In patients suffering multiple sclerosis activity despite treatment with interferon β or glatiramer acetate, clinicians often switch therapy to…”
Get full text
Journal Article -
15
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Published in Neurology (25-10-2022)“…To evaluate the rate of return of disease activity after cessation of multiple sclerosis (MS) disease-modifying therapy. This was a retrospective cohort study…”
Get full text
Journal Article -
16
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis
Published in JAMA neurology (01-04-2015)“…After multiple sclerosis (MS) relapse while a patient is receiving an injectable disease-modifying drug, many physicians advocate therapy switch, but the…”
Get more information
Journal Article -
17
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Published in Computer methods and programs in biomedicine (01-09-2021)“…•Temporal neural networks allow to significantly improve the prediction of disability progression in MS patients.•Disability progression can be predicted in a…”
Get full text
Journal Article -
18
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Published in Brain (London, England : 1878) (02-11-2023)“…Abstract Geographical variations in the incidence and prevalence of multiple sclerosis have been reported globally. Latitude as a surrogate for exposure to…”
Get full text
Journal Article -
19
3018 A multi-centre longitudinal study analysing disease modifying therapy prescribing patterns during the COVID-19 pandemic
Published in BMJ neurology open (01-08-2024)“…Background/ObjectivesThe COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapy (DMT), particularly anti-CD20 monoclonal antibodies…”
Get full text
Journal Article -
20
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
Published in Journal of neurology, neurosurgery and psychiatry (16-10-2024)“…BackgroundIt remains unclear whether routine cerebrospinal fluid (CSF) parameters can serve as predictors of multiple sclerosis (MS) disease course.MethodsThis…”
Get full text
Journal Article